CYP1A1 and lung cancer: This observation compares well with studies in other cell types where CYP1A1 activity has been positively correlated with pulmonary PAH (BPDE)-associated DNA adduction (26), and high CYP1A1 inducibility in lymphocytes has been related to a high lung cancer risk (27, 28).